Phase 3 clinical trials of Indian coronavirus vaccine manufacturer Bharat Biotech are conducted in partnership with the Indian Council for Medical Research (ICMR) lead medical body. Trials of its Covid-19 vaccine candidate, Covaxin, involving 26,000 participants at 22 sites across the country, began on November 16. It is the largest …
Read More »List of states that have started phase 3 trials of Covaxin
